Genetic polymorphisms of clusterin gene are associated with a decreased risk of Alzheimer's disease

European Journal of Epidemiology

Volumn 27, Issue 1, 2012, Pages 73-75

  Lin, Yen Ling ^a   Chen, Shih Yuan ^a   Lai, Liang Chuan ^b   Chen, Jen Hau ^a,c   Yang, Shi Yi ^a   Huang, Yi Ling ^a   Chen, Ta Fu ^c   Sun, Yu ^d   Wen, Li Li ^d   Yip, Ping Keung ^e   Chu, Yi Min ^e   Chen, Wei J ^a   Chen, Yen Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d EN CHU KONG HOSPITAL   (Taiwan)

^e CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CLUSTERIN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHROMOSOME 8P; CLUSTERIN GENE; CONTROLLED STUDY; EDUCATIONAL STATUS; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TAIWANESE; TEACHING HOSPITAL;

EID: 84862777587     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9650-5     Document Type: Letter

References (9)

1. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41:1094-9.
2. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41:1088-93.
3. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303:1832-40.
4. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010;19:3295-301.
5. Schjeide BM, Schnack C, Lambert JC, Lill CM, Kirchheiner J, Tumani H, et al. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Arch Gen Psychiatry. 2011;68:207-13.
6. Tycko B, Feng L, Nguyen L, Francis A, Hays A, Chung WY, et al. Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Hum Genet. 1996;98:430-6. (Pubitemid 26336167)
7. Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, Schott JM, et al. Genetic variability in CLU and its association with Alzheimer's disease. PLoS One. 2010;5:e9510.
8. Yu JT, Li L, Zhu QX, Zhang Q, Zhang W, Wu ZC, et al. Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. Clin Chim Acta. 2010;411:1516-9.
9. Harr SD, Uint L, Hollister R, Hyman BT, Mendez AJ. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem. 1996;66:2429-35. (Pubitemid 26159078)